Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.38 --0%
Revenue Growth %: +5.9%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +5.9%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q2 EPS of $0.17, $0.08 better than the analyst estimate of $0.09. Revenue for the quarter came in at $36.4 million versus the consensus estimate of $31.51 million.
For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
- Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
